Scinovex
article Open AccessTop 1% cited

Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes

Diabetes · 2005 · Vol. 54(3) · pp. 603–608
Kitt Falk PetersenSylvie DufourDouglas E. BefroyMichael LehrkeRosa E. HendlerGerald I. Shulman

Abstract

To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-(2)H(2)]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02) and IMCL (2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02) compared with the control subjects. A weight loss of only approximately 8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 +/- 7 vs. 153 +/- 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 +/- 22 vs. 99 +/- 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 +/- 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.

Liver Disease Diagnosis and TreatmentDiet and metabolism studiesAdipose Tissue and MetabolismInternal medicineEndocrinologyInsulin resistanceInsulinType 2 diabetesDiabetes mellitusSteatosisCarbohydrate metabolismBasal (medicine)Medicine

MeSH terms

AdultDiabetes Mellitus, Type 2Fatty LiverFemaleGluconeogenesisHumansHyperglycemiaInsulin ResistanceLiverLiver GlycogenMaleMiddle AgedMagnetic Resonance SpectroscopyWeight Loss

Funding

  • Howard Hughes Medical Institute
  • American Diabetes Association
  • Yale University
  • Deutsches Krebsforschungszentrum
  • U.S. Public Health Service
Citations
890
FWCI
31.23
field-weighted impact
References
40
Percentile
100%
vs. same field & year
Citations per year
References
Cellular mechanisms of insulin resistance
Journal of Clinical Investigation · 2000 · 2,688 citations
Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo
American Journal of Physiology-Endocrinology and Metabolism · 1999 · 685 citations
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
New England Journal of Medicine · 1996 · 6,327 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes · Scinovex